Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / AMLX - The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals Inc. (AMLX) Shareholders | Benzinga

AMLX - The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals Inc. (AMLX) Shareholders | Benzinga

Amylyx Pharmaceuticals Inc.

  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX).

    Shareholders who purchased shares of AMLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

    CONTACT US HERE:

    https://securitiesclasslaw.com/securities/amylyx-loss-submission-form/?id=72804&from=3

    CLASS PERIOD: November 11, 2022 to November 8, 2023

    ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) defendants had overstated commercial prospects RELYVRIO, a dual UPRBax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the ...

    AMLX) Shareholders>Full story available on Benzinga.com

    •
    Stock Information
    Company Name: Amylyx Pharmaceuticals Inc.
    Stock Symbol: AMLX
    Market: NASDAQ
    Website: amylyx.com
    Menu
    AMLX AMLX Quote AMLX Short AMLX News AMLX Articles AMLX Message Board
    Get AMLX Alerts

    News, Short Squeeze, Breakout and More Instantly...